Smooth Muscle Cell Reprogramming in Aortic Aneurysms

The etiology of aortic aneurysms is poorly understood, but it is associated with atherosclerosis, hypercholesterolemia, and abnormal transforming growth factor β (TGF-β) signaling in smooth muscle. Here, we investigated the interactions between these different factors in aortic aneurysm development...

Full description

Saved in:
Bibliographic Details
Published inCell stem cell Vol. 26; no. 4; pp. 542 - 557.e11
Main Authors Chen, Pei-Yu, Qin, Lingfeng, Li, Guangxin, Malagon-Lopez, Jose, Wang, Zheng, Bergaya, Sonia, Gujja, Sharvari, Caulk, Alexander W, Murtada, Sae-Il, Zhang, Xinbo, Zhuang, Zhen W, Rao, Deepak A, Wang, Guilin, Tobiasova, Zuzana, Jiang, Bo, Montgomery, Ruth R, Sun, Lele, Sun, Hongye, Fisher, Edward A, Gulcher, Jeffrey R, Fernandez-Hernando, Carlos, Humphrey, Jay D, Tellides, George, Chittenden, Thomas W, Simons, Michael
Format Journal Article
LanguageEnglish
Published United States 02.04.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The etiology of aortic aneurysms is poorly understood, but it is associated with atherosclerosis, hypercholesterolemia, and abnormal transforming growth factor β (TGF-β) signaling in smooth muscle. Here, we investigated the interactions between these different factors in aortic aneurysm development and identified a key role for smooth muscle cell (SMC) reprogramming into a mesenchymal stem cell (MSC)-like state. SMC-specific ablation of TGF-β signaling in Apoe mice on a hypercholesterolemic diet led to development of aortic aneurysms exhibiting all the features of human disease, which was associated with transdifferentiation of a subset of contractile SMCs into an MSC-like intermediate state that generated osteoblasts, chondrocytes, adipocytes, and macrophages. This combination of medial SMC loss with marked increases in non-SMC aortic cell mass induced exuberant growth and dilation of the aorta, calcification and ossification of the aortic wall, and inflammation, resulting in aneurysm development.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
AUTHOR CONTRIBUTIONS
PYC, LQ, GL, ZW, SB, AWC, SM, XZ, ZWZ, DAR, GW, ZT, and BJ performed experiments and generated data. JML, SG, JRG, TWC carried out bioinformatics studies. RRM assisted with studies of IMC and CyTOF. LS and HS performed sequencing. EAF, CFH, and JDH assisted with inflammation and biomechanical studies. PYC and MS wrote the manuscript. TWC, GT and MS supervised the project and provided funding.
Lead contact: Michael Simons, Yale Cardiovascular Research Center, 3oo George St, Suite 773, New Haven, CT 06511, USA. Phone: 203.737.4643; Fax: 203.737.5528
ISSN:1934-5909
1875-9777
1875-9777
DOI:10.1016/j.stem.2020.02.013